Although the effect of Anillin knockdown on sensitivity to tanespimycin was relatively modest (Fig. 5E), it suggests a potential relationship between HSP90 inhibitor efficacy and Anillin levels—which, as we have discussed, is overexpressed in several cancers. This evidence concerns the gene HSP90AA1 and cancer.